Monday, November 23, 2020 1:32:53 PM
The talk of equal price to Rem for treatment courses conflicts with the statement of easy production and low costs.?. That is for the IV?
Maybe this is the start of Partnerships and requests for the Drug Dr J also talked about recently.
The Inhaled version with the ease of application seems the needed target to expedite into the start of their clinical Trials whether here or in Eu / Israel.
The additional shares may be also to finance this. Maybe they are also for working the NRX IPO and bringing RLF into that new entity.
A R/S leaves the MC the same but will consolidate everything with an updated collective NRX/RLF proxy for the future. GEM/Insiders have control thru the Large holdings and I expect a surprise. No vote by common shareholders is really necessary, IMO...
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM